tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Algernon Pharmaceuticals Expands into Alzheimer’s Market with Strategic Acquisition
PremiumCompany AnnouncementsAlgernon Pharmaceuticals Expands into Alzheimer’s Market with Strategic Acquisition
4M ago
Algernon Pharmaceuticals to acquire NoBrainer Imaging Centers
Premium
The Fly
Algernon Pharmaceuticals to acquire NoBrainer Imaging Centers
4M ago
Algernon Pharmaceuticals Extends Warrant Expiry Date to November 2025
Premium
Company Announcements
Algernon Pharmaceuticals Extends Warrant Expiry Date to November 2025
4M ago
Algernon Pharmaceuticals appoints Sandor Nardai as OI for Phase 2a DMT study
PremiumThe FlyAlgernon Pharmaceuticals appoints Sandor Nardai as OI for Phase 2a DMT study
7M ago
Algernon NeuroScience Partners with Validcare for Pioneering Stroke Study
Premium
Company Announcements
Algernon NeuroScience Partners with Validcare for Pioneering Stroke Study
7M ago
Psychedelic: Relmada acquires neurosteroid from Asarina
Premium
The Fly
Psychedelic: Relmada acquires neurosteroid from Asarina
7M ago
Algernon Pharmaceuticals Secures Funding Through Private Placement
PremiumCompany AnnouncementsAlgernon Pharmaceuticals Secures Funding Through Private Placement
1y ago
Algernon Pharmaceuticals Boosts Private Placement
Premium
Company Announcements
Algernon Pharmaceuticals Boosts Private Placement
1y ago
Algernon Pharmaceuticals Launches Private Placement
Premium
Company Announcements
Algernon Pharmaceuticals Launches Private Placement
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100